Michael J. Angelakis - Nov 20, 2024 Form 4 Insider Report for CLARIVATE PLC (CLVT)

Role
Director
Signature
/s/ Clare McGrory, as Attorney-in-Fact
Stock symbol
CLVT
Transactions as of
Nov 20, 2024
Transactions value $
$17,863,350
Form type
4
Date filed
11/22/2024, 06:28 PM
Previous filing
May 8, 2024
Next filing
Jan 3, 2025

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $5.21 inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.04 to $5.24 inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.08 to $5.25 inclusive.
F4 The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which these transactions were effected.
F5 Reflects ordinary shares of Clarivate held directly by Atairos Strategic Partners, L.P. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the sole member of Atairos Strategic Partners GP, LLC, which is the general partner of Atairos Strategic Partners, L.P.
F6 Reflects ordinary shares of Clarivate held directly by A-PQ Holdings. Mr. Angelakis directly or indirectly controls a majority of the voting power of Atairos Partners GP, Inc. Atairos Partners GP, Inc. is the general partner of Atairos Partners, L.P., which is the sole voting shareholder of Atairos Group, Inc. Atairos Group, Inc. is the sole member of A-PQ Holdings.
F7 Mr. Angelakis disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.